Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Observational Study on the Efficacy and Safety of Anti HER2 Therapy

NCT05367739 is registered in ClinicalTrials.gov with Hunan Cancer Hospital as lead sponsor.

NCT NCT05367739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05367739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Observational Study on the Efficacy and Safety of Anti HER2 Therapy
Lead sponsor
Hunan Cancer Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
July 1, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, her2-positive breast cancer